Joshua T. Sarafian

Joshua T. Sarafian

Auto-generated profile, based on publicly available information

Joshua T. Sarafian

From the Duke Global Health Institute, Duke University, Durham, NC

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
APAlena Pauley
Alena Pauley
ETEmily C. Thatcher
Emily C. Thatcher
JSJoshua T. Sarafian
Joshua T. Sarafian
SZSiddhesh Zadey
Siddhesh Zadey
FSFrida Shayo
Frida Shayo
CSCatherine A Staton
Catherine A Staton
Background: Alcohol is a leading behavioral risk factor for death and disability worldwide. Tanzania has few trained personnel and resources for treating unhealthy alcohol use. In Emergency Medicine Departments (EMDs), alcohol is a well-known risk factor for injury patients. At Kilimanjaro Christian Medical Center (KCMC) in Moshi, Tanzania, 30% of EMD injury patients (IP) test positive for alcohol upon arrival to the ED. While the IP population is prime for EMD-based interventions, there is limited data on if non-injury patients (NIP) have similar alcohol use behavior and potentially benefit from screening and intervention as well. Methods: This was a secondary analysis of a systematic random sampling of adult (≥18 years old), KiSwahili speaking, KCMC EMD patients surveyed between October 2021 and May 2022. When medically stable and clinically sober, participants provided informed consent. Information on demographics (sex, age, years of education, type of employment, income, marital status, tribe, and religion), injury status, self-reported alcohol use, and Alcohol Use Disorder (AUD) Identification Test (AUDIT) scores were collected. Descriptive statistics were analyzed in RStudio using frequencies and proportions. Results: Of the 376 patients enrolled, 59 (15.7%) presented with an injury. The IP and NIP groups did not differ in any demographics except sex, an expected difference as females were intentionally oversampled in the original study design. The mean [SD] AUDIT score (IP: 5.8 [6.6]; NIP: 3.9 [6.1]), drinks per week, and proportion of AUDIT ≥8 was higher for IP (IP:37%; NIP: 21%). However, alcohol preferences, drinking quantity, weekly expenditure on alcohol, perceptions of unhealthy alcohol use, attempts and reasons to quit, and treatment seeking were comparable between IPs and NIPs. Conclusion: Our data suggests 37% of injury and 20% of non-injury patients screen positive for harmful or hazardous drinking in our setting. An EMD-based alcohol treatment and referral process could be beneficial to reduce this growing behavioral risk factor in non-injury as well as injury populations.

4 May 2023 in medRxiv
Verified
Preprint
Open access
PDF file
APAlena Pauley
Alena Pauley
ETEmily C. Thatcher
Emily C. Thatcher
JSJoshua T. Sarafian
Joshua T. Sarafian
SZSiddhesh Zadey
Siddhesh Zadey
FSFrida Shayo
Frida Shayo
CSCatherine A Staton
Catherine A Staton
Background Alcohol is a leading behavioral risk factor for death and disability worldwide. Tanzania has few trained personnel and resources for treating unhealthy alcohol use. In Emergency Medicine Departments (EMDs), alcohol is a well-known risk factor for injury patients. At Kilimanjaro Christian Medical Center (KCMC) in Moshi, Tanzania, 30% of EMD injury patients (IP) test positive for alcohol upon arrival to the ED. While the IP population is prime for EMD-based interventions, there is limited data on if non-injury patients (NIP) have similar alcohol use behavior and potentially benefit from screening and intervention as well. Methods This was a secondary analysis of a systematic random sampling of adult (≥18 years old), KiSwahili speaking, KCMC EMD patients surveyed between October 2021 and May 2022. When medically stable and clinically sober, participants provided informed consent. Information on demographics (sex, age, years of education, type of employment, income, marital status, tribe, and religion), injury status, self-reported alcohol use, and Alcohol Use Disorder (AUD) Identification Test (AUDIT) scores were collected. Descriptive statistics were analyzed in Rstudio using frequencies and proportions. Results Of the 376 patients enrolled, 59 (15.7%) presented with an injury. The IP and NIP groups did not differ in any demographics except sex, an expected difference as females were intentionally oversampled in the original study design. The mean [SD] AUDIT score (IP: 5.8 [6.6]; NIP: 3.9 [6.1]), drinks per week, and proportion of AUDIT ≥8 was higher for IP (IP:37%; NIP: 21%). However, alcohol preferences, drinking quantity, weekly expenditure on alcohol, perceptions of unhealthy alcohol use, attempts and reasons to quit, and treatment seeking were comparable between IPs and NIPs. Conclusion Our data suggests 37% of injury and 20% of non-injury patients screen positive for harmful or hazardous drinking in our setting. An EMD-based alcohol treatment and referral process could be beneficial to reduce this growing behavioral risk factor in non-injury as well as injury populations.

21 November 2024 in American Heart Journal
Verified
Journal Article
Closed access
JSJoshua T. Sarafian
Joshua T. Sarafian
FSFrancis M. Sakita
Francis M. Sakita
JMJerome J. Mlangi
Jerome J. Mlangi
GKGodfrey L. Kweka
Godfrey L. Kweka
TTTumsifu G. Tarimo
Tumsifu G. Tarimo
JHJulian T. Hertz
Julian T. Hertz

14 November 2023 in Vaccine
Verified
Journal Article
Closed access
JSJoshua T. Sarafian
Joshua T. Sarafian
SEStephanie A. Eucker
Stephanie A. Eucker
MGMichael Gillman
Michael Gillman
ADAmy M. DeLaroche
Amy M. DeLaroche
RRRobert M. Rodriguez
Robert M. Rodriguez
BBBrigitte M. Baumann
Brigitte M. Baumann

23 July 2025 in JMIR Preprints
Verified
Preprint
Open access
AVAarushi Venkatakrishnan
Aarushi Venkatakrishnan
CSChelsea Swanson
Chelsea Swanson
APAntara Palkar
Antara Palkar
DTDavid Takamiya
David Takamiya
JSJoshua T. Sarafian
Joshua T. Sarafian
WPWilliam Parker
William Parker
BACKGROUND Helminth therapy holds considerable theoretical promise for clinical and public health applications. Unfortunately, clinical trials have often used helminths produced using methods that are both highly variable and insufficiently described in the literature, which may hinder reproducibility and troubleshooting. OBJECTIVE This study aimed to devise a method for purification of helminths that avoids mechanical filtration, which may damage some organisms. In particular, the goal was to devise a method to separate large quantities of cysticercoids of the cestode species Hymenolepis diminuta (HDCs), a process that has not been described previously but that would be necessary before HDCs can be used clinically. METHODS The physical size and behavior of HDCs in solution were assessed and used to create a patented washing device. RESULTS The cross-sectional area of HDCs varied over a 10-fold range, from approximately 0.06 to 0.6 mm2, dependent in large part upon the host. That cross-sectional area correlated in a linear fashion with the steady-state speed of HDCs while falling through solution, which varied over a 5-fold range, from approximately 0.4 mm/s to 2.0 mm/s in the solution tested. These parameters were used to develop a washing device that utilized a variable flow speed dictated by changing column diameter and an upward flowing column of liquid that effectively and simultaneously suspended HDCs of various sizes in a wash solution. CONCLUSIONS This study describes a detailed method of purification of HDCs, organisms that could potentially be used for helminth therapy. It is hoped that government agencies or non-profit organizations can use such technology to conduct rigorous clinical trials, potentially leading to the production of reasonably priced therapeutics. CLINICALTRIAL Not applicable